王辰、张亭栋获 2019 年度吴阶平医学奖!未来评审将严把学术道德

2019-12-02 崔鑫竹 健康界

12月1日,2019年吴阶平医学奖颁奖大会在广东省中山市举行。吴阶平医学基金会理事长晓萌宣布,王辰、张亭栋荣获2019年度吴阶平医学奖,董晨、张卫东、王伟、令狐恩强、王升启、陈翔六位教授获得2019年度吴阶平医药创新奖。微信图片_20191201155528.jpg吴阶平医学奖获奖者:除了感谢,还有继承中国工程院院士、中国医学科学院北京协和医学院院校长王辰教授,长期从事肺栓塞与肺动脉高压、呼吸

12月1日,2019年吴阶平医学奖颁奖大会在广东省中山市举行。吴阶平医学基金会理事长晓萌宣布,王辰、张亭栋荣获2019年度吴阶平医学奖,董晨、张卫东、王伟、令狐恩强、王升启、陈翔六位教授获得2019年度吴阶平医药创新奖。


吴阶平医学奖获奖者:除了感谢,还有继承

中国工程院院士、中国医学科学院北京协和医学院院校长王辰教授,长期从事肺栓塞与肺动脉高压、呼吸衰竭与呼吸支持技术、新发呼吸道传染病、慢性阻塞性肺疾病、烟草病学等领域的医教研防工作。他建立覆盖全国肺栓塞防治协作网、推动成果转化与规范诊治,使肺栓塞诊断例数成倍增加,住院病死率大幅下降。

王辰在获奖感言中道出吴阶平医学奖对他的特殊意义,以及他和吴阶平的特殊渊源。“我毕业于吴阶平先生创办的北京第二医学院,而吴阶平先生就是我现在所工作的中国医学科学院北京协和医学院的老院校长,我们是他的继承者。我从上学的时候,就深受吴阶平的很多思想影响,他的思维方法、治学态度、学习方法,都对我学生时期的成长起到了至关重要的作用。我也非常荣幸曾经作为医生对吴阶平先生进行诊治。所以我总觉着跟吴阶平先生有一种很深刻的联系。当我担任中国医学科学院北京协和医学院院校长的时候,我的办公室和办公室对面的房子,都是吴阶平院校长曾经工作的地方。我在办公室无意中发现一张吴阶平先生过去的名片,这张名片我一直珍藏,我想这也是冥冥中的一种渊源。”王辰说。

中西医结合血液病学专家、哈尔滨医科大学附属第一医院张亭栋教授是砒霜(三氧化二砷)治疗白血病的奠基人。他于1973年发表的第一篇“癌灵注射液”治疗白血病患者的临床观察研究,是最早应用亚砷酸治疗白血病的文章。张亭栋教授团队研究确定了亚砷酸是治疗急性早幼粒细胞白血病特效药。

由于身体状况不好,张亭栋教授未能到场。由哈尔滨医科大学附属第一医院副院长魏云巍代其发表感言,“首先,感谢吴阶平基金会颁给他的此次殊荣。第二,他的‘三氧化二砷’仅仅是中国医药的发明之一。但是这还不够,希望中国医药有更多发明创造,中国医药是一个伟大的待发掘的宝库。这些发明不仅治好中国人的病,更治好全世界人民的病。”

韩启德院士:未来评审要严把学术道德

免疫学专家、清华大学医学院院长、中国科学院院士董晨教授的研究已被写入经典教科书,为人类攻克自身免疫疾病提供了必要的科学基础。他长期运用小鼠遗传学、免疫学、生物化学和基因组学等方法研究T细胞功能调控,有系统的创造性的接触贡献,为自身免疫疾病和肿瘤的免疫治疗提供了重要思路。“今后要不忘初心,继续奋进。做出更大的成果,同时要培养好青年人才。”董晨说。

皮肤病与性病学专家、中南大学副校长陈翔教授一直开展围绕以黑素瘤为主的皮肤肿瘤的基础研究,历经20年持续攻关,其研究为皮肤肿瘤的靶向治疗奠定了坚实的基础,为实现银屑病的精准医学提供了坚实的基础。陈翔表示,“一定在其他工作中,为中国的医学教育事业,以及皮肤的健康和疾病的防控事业做出应有的贡献。”

天然药物化学专家、中国人民解放军海军军医大学药学院副院长张卫东教授主要从事中药及复方的药效物质基础、天然产物的化学生物学以及创新药物研究,推动中药科学内涵的发展和创新药物的研发。“一定学习吴阶平院士大爱的精神,为国、为党奉献的精神,把中医药的瑰宝发扬光大。”张卫东说。

消化病学及消化内镜学专家、中国人民解放军总医院第一医学中心消化内科主任令狐恩强教授是消化内科行业第一位获得吴阶平医药创新奖的研究者,他定名并完善了消化内镜隧道技术理论,打破了传统内科和外科的界限。令狐恩强表示,“非常感谢吴阶平基金会将这份殊荣给了我们行业。我将沿着吴阶平院士所提出‘实践、思考、学习(知识)’的理念,继续深耕于医学事业。”

中西医结合临床与药理学专家、北京中医药大学副校长王伟教授主要研究中医治疗心血管病的基础与临床、中医证候与脏象研究。他的研究对于揭示证候和肝主疏泄的科学内涵、提高临床辩证水平探索中医理论基础研究方法都有重要意义。“我将以此次获奖作为一个起点,继续在中西结合的道路上进行新的探索。”王伟说。

军事预防医学和生物医学工程学专家、中国人民解放军军事科学院军事医学研究院王升启研究员长期致力于军事医学研究,是我国传染病分子诊断领域的主要开拓者。他在获奖感言中表示,“衷心感谢老一辈医药学家对我国医学事业作出的贡献,我们以后将以他们为榜样,努力做好自己的本职工作。为我国军事医学事业做出更大的贡献,保障我国生物安全。”

吴阶平医学奖评审委员会主席、中国科学院院士韩启德表示,“吴老总会离开我们的,但他留下了无穷的遗产。人不是简单的物种,因为人除了身体基因的传承,还有精神基因的传承。像今天吴阶平医学奖、吴阶平医药创新奖的获奖者,都是在继承吴老的精神基因。”

对于未来吴阶平医学奖的评审工作,他提出三点建议:第一,在评审的过程当中,一定要更加注重获奖者的品行,严把学术道德;第二,要争取把更多的锦上添花转变为雪中送炭,应该扶持更多的年轻人,让他们在获奖后受到更大鼓舞;第三,要大力宣传获奖者的成绩及优秀品质,扩大吴阶平医学奖的影响,要达到评奖的目的。使吴阶平医学奖在中国医药事业发展中、在中国特色社会主义建设中发挥更大的作用。

经国家科技部批准设立的吴阶平医学奖和吴阶平医药创新奖每年颁发一次。吴阶平医学奖授予促进中国医学科学技术进步,为我国医疗卫生事业发展做出突出贡献的个人。吴阶平医药创新奖主要奖励59周岁以下,在医学、药学研究和应用领域取得创新性成就的中青年医药工作者。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1757380, encodeId=d0dd1e57380b8, content=<a href='/topic/show?id=a86b455913b' target=_blank style='color:#2F92EE;'>#学术道德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45591, encryptionId=a86b455913b, topicName=学术道德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f09c37314008, createdName=12498636m61(暂无昵称), createdTime=Fri May 08 22:57:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668485, encodeId=774c1668485cc, content=<a href='/topic/show?id=32fa49908f4' target=_blank style='color:#2F92EE;'>#张亭栋#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49908, encryptionId=32fa49908f4, topicName=张亭栋)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705326322596, createdName=wfang554, createdTime=Tue Mar 31 12:57:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457297, encodeId=70b4145e29786, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543522, encodeId=2cfe1543522e3, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575405, encodeId=014f15e540547, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376207, encodeId=f57b3e620701, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:36 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376206, encodeId=f8be3e620656, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:33 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376205, encodeId=ff943e620546, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:30 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376204, encodeId=de533e620439, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:05 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376203, encodeId=b2f83e6203f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:02 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1757380, encodeId=d0dd1e57380b8, content=<a href='/topic/show?id=a86b455913b' target=_blank style='color:#2F92EE;'>#学术道德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45591, encryptionId=a86b455913b, topicName=学术道德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f09c37314008, createdName=12498636m61(暂无昵称), createdTime=Fri May 08 22:57:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668485, encodeId=774c1668485cc, content=<a href='/topic/show?id=32fa49908f4' target=_blank style='color:#2F92EE;'>#张亭栋#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49908, encryptionId=32fa49908f4, topicName=张亭栋)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705326322596, createdName=wfang554, createdTime=Tue Mar 31 12:57:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457297, encodeId=70b4145e29786, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543522, encodeId=2cfe1543522e3, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575405, encodeId=014f15e540547, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376207, encodeId=f57b3e620701, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:36 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376206, encodeId=f8be3e620656, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:33 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376205, encodeId=ff943e620546, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:30 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376204, encodeId=de533e620439, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:05 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376203, encodeId=b2f83e6203f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:02 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1757380, encodeId=d0dd1e57380b8, content=<a href='/topic/show?id=a86b455913b' target=_blank style='color:#2F92EE;'>#学术道德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45591, encryptionId=a86b455913b, topicName=学术道德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f09c37314008, createdName=12498636m61(暂无昵称), createdTime=Fri May 08 22:57:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668485, encodeId=774c1668485cc, content=<a href='/topic/show?id=32fa49908f4' target=_blank style='color:#2F92EE;'>#张亭栋#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49908, encryptionId=32fa49908f4, topicName=张亭栋)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705326322596, createdName=wfang554, createdTime=Tue Mar 31 12:57:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457297, encodeId=70b4145e29786, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543522, encodeId=2cfe1543522e3, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575405, encodeId=014f15e540547, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376207, encodeId=f57b3e620701, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:36 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376206, encodeId=f8be3e620656, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:33 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376205, encodeId=ff943e620546, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:30 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376204, encodeId=de533e620439, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:05 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376203, encodeId=b2f83e6203f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:02 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-04 zhmscau
  4. [GetPortalCommentsPageByObjectIdResponse(id=1757380, encodeId=d0dd1e57380b8, content=<a href='/topic/show?id=a86b455913b' target=_blank style='color:#2F92EE;'>#学术道德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45591, encryptionId=a86b455913b, topicName=学术道德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f09c37314008, createdName=12498636m61(暂无昵称), createdTime=Fri May 08 22:57:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668485, encodeId=774c1668485cc, content=<a href='/topic/show?id=32fa49908f4' target=_blank style='color:#2F92EE;'>#张亭栋#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49908, encryptionId=32fa49908f4, topicName=张亭栋)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705326322596, createdName=wfang554, createdTime=Tue Mar 31 12:57:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457297, encodeId=70b4145e29786, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543522, encodeId=2cfe1543522e3, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575405, encodeId=014f15e540547, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376207, encodeId=f57b3e620701, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:36 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376206, encodeId=f8be3e620656, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:33 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376205, encodeId=ff943e620546, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:30 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376204, encodeId=de533e620439, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:05 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376203, encodeId=b2f83e6203f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:02 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1757380, encodeId=d0dd1e57380b8, content=<a href='/topic/show?id=a86b455913b' target=_blank style='color:#2F92EE;'>#学术道德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45591, encryptionId=a86b455913b, topicName=学术道德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f09c37314008, createdName=12498636m61(暂无昵称), createdTime=Fri May 08 22:57:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668485, encodeId=774c1668485cc, content=<a href='/topic/show?id=32fa49908f4' target=_blank style='color:#2F92EE;'>#张亭栋#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49908, encryptionId=32fa49908f4, topicName=张亭栋)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705326322596, createdName=wfang554, createdTime=Tue Mar 31 12:57:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457297, encodeId=70b4145e29786, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543522, encodeId=2cfe1543522e3, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575405, encodeId=014f15e540547, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376207, encodeId=f57b3e620701, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:36 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376206, encodeId=f8be3e620656, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:33 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376205, encodeId=ff943e620546, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:30 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376204, encodeId=de533e620439, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:05 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376203, encodeId=b2f83e6203f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:02 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1757380, encodeId=d0dd1e57380b8, content=<a href='/topic/show?id=a86b455913b' target=_blank style='color:#2F92EE;'>#学术道德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45591, encryptionId=a86b455913b, topicName=学术道德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f09c37314008, createdName=12498636m61(暂无昵称), createdTime=Fri May 08 22:57:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668485, encodeId=774c1668485cc, content=<a href='/topic/show?id=32fa49908f4' target=_blank style='color:#2F92EE;'>#张亭栋#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49908, encryptionId=32fa49908f4, topicName=张亭栋)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705326322596, createdName=wfang554, createdTime=Tue Mar 31 12:57:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457297, encodeId=70b4145e29786, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543522, encodeId=2cfe1543522e3, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575405, encodeId=014f15e540547, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376207, encodeId=f57b3e620701, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:36 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376206, encodeId=f8be3e620656, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:33 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376205, encodeId=ff943e620546, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:30 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376204, encodeId=de533e620439, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:05 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376203, encodeId=b2f83e6203f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:02 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-02 14794e5bm67(暂无昵称)

    学习了,谢谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1757380, encodeId=d0dd1e57380b8, content=<a href='/topic/show?id=a86b455913b' target=_blank style='color:#2F92EE;'>#学术道德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45591, encryptionId=a86b455913b, topicName=学术道德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f09c37314008, createdName=12498636m61(暂无昵称), createdTime=Fri May 08 22:57:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668485, encodeId=774c1668485cc, content=<a href='/topic/show?id=32fa49908f4' target=_blank style='color:#2F92EE;'>#张亭栋#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49908, encryptionId=32fa49908f4, topicName=张亭栋)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705326322596, createdName=wfang554, createdTime=Tue Mar 31 12:57:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457297, encodeId=70b4145e29786, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543522, encodeId=2cfe1543522e3, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575405, encodeId=014f15e540547, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376207, encodeId=f57b3e620701, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:36 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376206, encodeId=f8be3e620656, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:33 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376205, encodeId=ff943e620546, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:30 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376204, encodeId=de533e620439, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:05 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376203, encodeId=b2f83e6203f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:02 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-02 14794e5bm67(暂无昵称)

    学习了,谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1757380, encodeId=d0dd1e57380b8, content=<a href='/topic/show?id=a86b455913b' target=_blank style='color:#2F92EE;'>#学术道德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45591, encryptionId=a86b455913b, topicName=学术道德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f09c37314008, createdName=12498636m61(暂无昵称), createdTime=Fri May 08 22:57:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668485, encodeId=774c1668485cc, content=<a href='/topic/show?id=32fa49908f4' target=_blank style='color:#2F92EE;'>#张亭栋#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49908, encryptionId=32fa49908f4, topicName=张亭栋)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705326322596, createdName=wfang554, createdTime=Tue Mar 31 12:57:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457297, encodeId=70b4145e29786, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543522, encodeId=2cfe1543522e3, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575405, encodeId=014f15e540547, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376207, encodeId=f57b3e620701, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:36 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376206, encodeId=f8be3e620656, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:33 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376205, encodeId=ff943e620546, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:30 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376204, encodeId=de533e620439, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:05 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376203, encodeId=b2f83e6203f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:02 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-02 14794e5bm67(暂无昵称)

    学习了,谢谢分享

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1757380, encodeId=d0dd1e57380b8, content=<a href='/topic/show?id=a86b455913b' target=_blank style='color:#2F92EE;'>#学术道德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45591, encryptionId=a86b455913b, topicName=学术道德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f09c37314008, createdName=12498636m61(暂无昵称), createdTime=Fri May 08 22:57:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668485, encodeId=774c1668485cc, content=<a href='/topic/show?id=32fa49908f4' target=_blank style='color:#2F92EE;'>#张亭栋#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49908, encryptionId=32fa49908f4, topicName=张亭栋)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705326322596, createdName=wfang554, createdTime=Tue Mar 31 12:57:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457297, encodeId=70b4145e29786, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543522, encodeId=2cfe1543522e3, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575405, encodeId=014f15e540547, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376207, encodeId=f57b3e620701, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:36 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376206, encodeId=f8be3e620656, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:33 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376205, encodeId=ff943e620546, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:30 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376204, encodeId=de533e620439, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:05 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376203, encodeId=b2f83e6203f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:02 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-02 14794e5bm67(暂无昵称)

    学习了,谢谢分享

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1757380, encodeId=d0dd1e57380b8, content=<a href='/topic/show?id=a86b455913b' target=_blank style='color:#2F92EE;'>#学术道德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45591, encryptionId=a86b455913b, topicName=学术道德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f09c37314008, createdName=12498636m61(暂无昵称), createdTime=Fri May 08 22:57:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1668485, encodeId=774c1668485cc, content=<a href='/topic/show?id=32fa49908f4' target=_blank style='color:#2F92EE;'>#张亭栋#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49908, encryptionId=32fa49908f4, topicName=张亭栋)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=705326322596, createdName=wfang554, createdTime=Tue Mar 31 12:57:00 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457297, encodeId=70b4145e29786, content=<a href='/topic/show?id=089e393e1c4' target=_blank style='color:#2F92EE;'>#吴阶平#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39371, encryptionId=089e393e1c4, topicName=吴阶平)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64955868177, createdName=zhmscau, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543522, encodeId=2cfe1543522e3, content=<a href='/topic/show?id=274e340e5fd' target=_blank style='color:#2F92EE;'>#医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34075, encryptionId=274e340e5fd, topicName=医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=250d13588803, createdName=斯嘉莉, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575405, encodeId=014f15e540547, content=<a href='/topic/show?id=fab8393e4f9' target=_blank style='color:#2F92EE;'>#吴阶平医学奖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39374, encryptionId=fab8393e4f9, topicName=吴阶平医学奖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd2816125954, createdName=s_pl2013, createdTime=Wed Dec 04 05:57:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376207, encodeId=f57b3e620701, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:36 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376206, encodeId=f8be3e620656, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:33 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376205, encodeId=ff943e620546, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:34:30 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376204, encodeId=de533e620439, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:05 CST 2019, time=2019-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376203, encodeId=b2f83e6203f2, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Mon Dec 02 16:33:02 CST 2019, time=2019-12-02, status=1, ipAttribution=)]
    2019-12-02 14794e5bm67(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

重磅揭晓!程天民、陈赛娟院士荣获2017年吴阶平医学奖

10月13日,由吴阶平医学基金会主办,健康界传媒承办的“吴阶平医学奖、吴阶平医药创新奖新闻发布会”在京召开,2017年吴阶平医学奖、吴阶平医药创新奖获奖名单正式揭晓。经吴阶平医学奖评审委员会终审会议决定和确认,中国工程院院士程天民、陈赛娟荣获“2017年吴阶平医学奖”, 表彰他们对中国防原医学(核防护医学)和血液学科发展所做出的突出贡献。

重磅揭晓!程天民、陈赛娟院士荣获2017年吴阶平医学奖

10月13日,由吴阶平医学基金会主办,健康界传媒承办的“吴阶平医学奖、吴阶平医药创新奖新闻发布会”在京召开,2017年吴阶平医学奖、吴阶平医药创新奖获奖名单正式揭晓。

2017年吴阶平医学奖和医药创新奖颁奖典礼举办在即

11月9-10日,第十二届健康与发展中山论坛、2017年吴阶平医学奖颁奖大会将在广东省中山市举行。

2017年吴阶平医学奖揭晓

10月13日,2017年吴阶平医学奖、吴阶平医药创新奖在京揭晓。经吴阶平医学奖评审委员会各评委无记名投票,将2017年吴阶平医学奖授予中国工程院院士、陆军军医大学防原医学与病理学家程天民和中国工程院院士、上海交通大学医学院细胞与分子遗传学专家陈赛娟,以表彰他们对中国防原医学(核防护医学)和血液学科发展所做出的突出贡献。

专注一件事 2017年吴阶平医学奖背后的故事

11月10日,2017年吴阶平医学奖颁奖大会在广东省中山市举行。同往年相比,此次颁奖大会意义非凡,获奖人数创新高。程天民、陈赛娟院士获2017年吴阶平医学奖,2017年吴阶平医药创新奖迎来了王松灵、李建生、高兴华、龚启勇、屠鹏飞和蒋建新六位获奖人。微信图片_20171110195135.jpg2017年吴阶平医学奖、医药创新奖获奖者及颁奖嘉宾合影吴阶平医学奖获奖者:专注做一件事作为我国防原医学的主

张伯礼院士荣获2016年吴阶平医学奖

张伯礼院士荣获2016年吴阶平医学奖,王喜军、刘祖国、黄晓军和蔡秀军教授分获2016年吴阶平医药创新奖。11月24日,吴阶平医学基金会对外公布,将2016年吴阶平医学奖授予张伯礼院士,以表彰他对中国中药现代化研究和中医药发展所做出的杰出贡献。同时公布的还有2016年吴阶平医药创新奖,分别授予王喜军教授、刘祖国教授、黄晓军教授、蔡秀军教授,以表彰四位获奖人在他们各自学科领域中所做出的创新性成就和突出